Updates from IMbrave 150 in HCC

  Рет қаралды 214

VJOncology

VJOncology

4 жыл бұрын

Daneng Li, MD, of City of Hope National Medical Center, Duarte, CA, discusses results from older adults enrolled in IMbrave150 (NCT03434379), a study investigating atezolizumab and bevacizumab vs sorafenib for unresectable hepatocellular carcinoma (HCC). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Пікірлер
Light Adaptation and Glaucoma  | Driving with Dr. David Richardson Ep 06
8:05
San Marino Eye | David D. Richardson, MD, Inc.
Рет қаралды 15 М.
Dr. Jeffrey Weitzel on Synthetic Lethality in BRCA-Associated Cancer
3:24
Targeted Oncology
Рет қаралды 3,8 М.
Fast and Furious: New Zealand 🚗
00:29
How Ridiculous
Рет қаралды 45 МЛН
Я обещал подарить ему самокат!
01:00
Vlad Samokatchik
Рет қаралды 9 МЛН
Doing This Instead Of Studying.. 😳
00:12
Jojo Sim
Рет қаралды 22 МЛН
Can A Seed Grow In Your Nose? 🤔
00:33
Zack D. Films
Рет қаралды 29 МЛН
Soft Tissue Sarcoma: Factors Impacting Initial Approach
5:34
What's Exciting About Bimatoprost SR Glaucoma Drug Implant
6:56
San Marino Eye | David D. Richardson, MD, Inc.
Рет қаралды 3,2 М.
Practical Experience with Iron Chelating Agents
7:46
OncLive
Рет қаралды 2 М.
Disease State Advanced Soft Tissue Sarcoma
3:00
OncLive
Рет қаралды 1,4 М.
Meet Hematologist Alex F. Herrera, M.D. | City of Hope
1:36
City of Hope
Рет қаралды 1,9 М.
The Top 5 Best Supplements For Gut Healing
13:38
Dr. Michael Ruscio, DC, DNM
Рет қаралды 4,6 М.
Fast and Furious: New Zealand 🚗
00:29
How Ridiculous
Рет қаралды 45 МЛН